Nkarta - Stock Price History | NKTX

Historical daily share price chart and data for Nkarta since 2021 adjusted for splits. The latest closing stock price for Nkarta as of September 24, 2021 is 30.15.
  • The all-time high Nkarta stock closing price was 75.62 on December 23, 2020.
  • The Nkarta 52-week high stock price is 79.16, which is 162.6% above the current share price.
  • The Nkarta 52-week low stock price is 23.02, which is 23.6% below the current share price.
  • The average Nkarta stock price for the last 52 weeks is 37.43.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Nkarta Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 35.8001 47.9000 75.6200 23.5200 61.4700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.012B $0.000B
Nkarta Inc. is a biopharmaceutical company. It develops and commercializes cell therapies for cancer treatment. The company's product candidate includes NKX101 and NKX019, which are in clinical stage. Nkarta Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71